Immunovant, Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
DEFA14A Oct 29, 2019 CURRENT REPORT
8-K Oct 29, 2019 CURRENT REPORT
DEFA14A Oct 15, 2019 CURRENT REPORT
8-K Oct 15, 2019 CURRENT REPORT
DEFA14A Oct 8, 2019 CURRENT REPORT
8-K Oct 8, 2019 CURRENT REPORT
SC 13G Oct 8, 2019
DEFA14A Oct 4, 2019 CURRENT REPORT
8-K Oct 4, 2019 CURRENT REPORT
PREM14A Oct 2, 2019 PRELIMINARY PROXY STATEMENT
8-K Oct 2, 2019 FORM 8-K
DEFA14A Oct 2, 2019 FORM 8-K
8-K Aug 26, 2019 CURRENT REPORT
10-Q Aug 12, 2019 QUARTERLY REPORT
10-Q Jun 12, 2019 10-Q
SC 13G May 22, 2019 SCHEDULE 13G
SC 13G May 20, 2019
8-K/A May 20, 2019 8-K/A
SC 13G May 20, 2019 HEALTH SCIENCES ACQUISITIONS CORPORATION
8-K May 15, 2019 FORM 8-K
4 May 15, 2019 FORM 4
424B4 May 10, 2019 424B4
EFFECT May 9, 2019
3 May 9, 2019 FORM 3
3 May 9, 2019 FORM 3
← Newer Page 25 of 26 · 646 filings Older →